Author: Ann

During the month of June, people all over the world come together to celebrate Pride Month and to raise awareness of the LGBTQIA+ community. At Chanelle Pharma, we always strive for equality inclusivity and diversity as well as a commitment to ensuring everyone feels respected, valued, and appreciated. To celebrate Pride Month, our National Account […]

Chanelle Pharma announces successful compilation of new Bisoprolol tablets dossier. Chanelle Pharma is pleased to announce that we have successfully finalised a new dossier for Bisoprolol (1.25mg, 2.5mg, 3.75mg, 5mg, 7.5mg, and 10mg). A β-Blocker medication, Bisoprolol is considered a key therapeutic option for people with Heart failure, Hypertension, and Angina. Chanelle previously launched Bisoprolol […]

Chanelle Pharma is pleased to announce the appointment of Aubrey Mulveen to the new position of Chief Financial Officer (CFO). Aubrey joins from C&D Foods, a division of ABP Group, one of Ireland’s largest and most successful family run businesses, where he has been CFO for the last six years.  Aubrey brings extensive experience in […]

The Chanelle Pharma team are excited to be returning to CPhI in Milan this year!

€5 million investment to create 60 jobs over next 5 years.

Michael Burke, founder of Ireland’s largest indigenous pharmaceuticals manufacturer to become Chairman and will continue to lead company’s R&D strategy

In the absence of CPHI Worldwide 2020, Chanelle Pharma’s Medical Team are hosting their first virtual sales event October 6th – November 6th. Book a meeting today!

Chanelle Pharma is delighted to announce it has shipped its first products to the US market following the granting of accreditation by the US Food and Drugs Administration (FDA) for its Spot On manufacturing facility in Loughrea, Co Galway.

At Chanelle Pharma, we believe we are stronger together. In these unprecedented times, we are focused on protecting the health of our employees, our customers, distributors, suppliers and our local community.